Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, LA.
Ochsner Clinical School, University of Queensland School of Medicine, New Orleans, LA.
Int Forum Allergy Rhinol. 2021 Aug;11(8):1177-1186. doi: 10.1002/alr.22771. Epub 2021 Jan 27.
Standardized diagnostic criteria for Eustachian tube (ET) dysfunction (ETD) have not been established. The purpose of this study was to characterize the relationship between ET inflammation and ETD symptoms and to determine the diagnostic performance of a quantitative score.
Patients were enrolled in a rhinology clinic between October 2018 and June 2019. Patients underwent nasal endoscopy and completed the 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Nasopharyngeal inflammation identified on endoscopy was quantified using the Endoscopic Evaluation of the Eustachian Tube (3ET) score. Tympanometry was performed as indicated. Comorbid conditions were assigned during the patient encounter.
A total of 414 patients were included in the study. Patients with clinically significant ETD symptoms (ETDQ-7 ≥2.1) had higher 3ET scores than those without symptoms. A 1-point increase in 3ET score was associated with a 1.7-fold increase in odds of clinically significant ETD symptoms (adjusted OR [aOR], 1.72; 95% CI, 1.46 to 2.05). The 3ET scores were correlated with ETDQ-7 scores (ρ = 0.54) and 22-item Sino-Nasal Outcome Test (SNOT-22) scores (ρ = 0.52). 3ET scores were not associated with tympanometric peak pressures. Patients with ETD symptoms were more likely to have laryngopharyngeal reflux (aOR, 2.71; 95% CI, 1.24 to 6.18). A 3ET score of 4 predicted symptomatic state in 80% of cases with a specificity of 97.8% and positive predictive value of 96.6%.
Inflammatory findings at the nasopharyngeal ET orifice are associated with clinically significant ETD symptoms. The 3ET score is specific for a symptomatic state and has potential clinical utility in the evaluation of suspected ETD. ©2021 ARSAAOA, LLC.
尚未建立标准化的咽鼓管(ET)功能障碍(ETD)诊断标准。本研究旨在描述 ET 炎症与 ETD 症状之间的关系,并确定定量评分的诊断性能。
患者于 2018 年 10 月至 2019 年 6 月在鼻科诊所接受登记。患者接受鼻内镜检查并完成 7 项咽鼓管功能障碍问卷(ETDQ-7)。内镜评估咽鼓管(3ET)评分用于量化内镜下咽鼓管咽口炎症。根据需要进行鼓室压测量。在患者就诊期间分配合并症。
共有 414 例患者纳入本研究。有临床显著 ETD 症状(ETDQ-7≥2.1)的患者 3ET 评分高于无症状患者。3ET 评分增加 1 分,临床显著 ETD 症状的几率增加 1.7 倍(调整比值比 [aOR],1.72;95%置信区间,1.46 至 2.05)。3ET 评分与 ETDQ-7 评分(ρ=0.54)和 22 项鼻-鼻窦结局测试(SNOT-22)评分(ρ=0.52)相关。3ET 评分与鼓室压峰值无相关性。有 ETD 症状的患者更有可能患有喉咽反流(aOR,2.71;95%置信区间,1.24 至 6.18)。3ET 评分为 4 预测有症状状态的准确率为 80%,特异性为 97.8%,阳性预测值为 96.6%。
咽鼓管咽口的炎症表现与临床显著的 ETD 症状相关。3ET 评分对症状状态具有特异性,在疑似 ETD 的评估中具有潜在的临床应用价值。